A brief mental health outcome scale-reliability and validity of the Global Assessment of Functioning (GAF)
- PMID: 7620753
- DOI: 10.1192/bjp.166.5.654
A brief mental health outcome scale-reliability and validity of the Global Assessment of Functioning (GAF)
Abstract
Background: The Global Assessment of Functioning (GAF) is a quick and simple measure of overall psychological disturbance. However, there is little research on the reliability and validity of this measure in severely mentally ill populations.
Method: Multidisciplinary keyworkers assessed 103 patients at monthly intervals over a 6-month period. Overall GAF scores were obtained, with additional separate ratings for symptoms and disability. These were compared with changes in antipsychotic medication and support needs over the same period.
Results: Satisfactory reliability was obtained for total GAF score and for symptom and disability measures, in spite of raters having only one brief training session. All GAF scores were associated with current support needs of patients. Symptom and disability scores were associated with changes in antipsychotic medication in the previous month. Only symptom score was associated with increases in antipsychotic medication at time of rating.
Conclusion: GAF proved to be a reliable and, within the limits of the indicators used, a valid measure of psychiatric disturbance in our sample of the severely mentally ill. Differences in relationships between the three GAF scores and medication/support needs indicate the usefulness of obtaining all three scores for monitoring levels and type of psychiatric disturbance in this population.
Similar articles
-
Global assessment of functioning. A modified scale.Psychosomatics. 1995 May-Jun;36(3):267-75. doi: 10.1016/S0033-3182(95)71666-8. Psychosomatics. 1995. PMID: 7638314
-
Axis V--Global Assessment of Functioning Scale. Evaluation of a self-report version.Acta Psychiatr Scand. 1994 Nov;90(5):342-7. doi: 10.1111/j.1600-0447.1994.tb01604.x. Acta Psychiatr Scand. 1994. PMID: 7872038
-
The MIRECC version of the Global Assessment of Functioning scale: reliability and validity.Psychiatr Serv. 2007 Apr;58(4):529-35. doi: 10.1176/ps.2007.58.4.529. Psychiatr Serv. 2007. PMID: 17412856
-
Global function scales.Soc Psychiatry Psychiatr Epidemiol. 1994 Sep;29(5):205-11. doi: 10.1007/BF00796379. Soc Psychiatry Psychiatr Epidemiol. 1994. PMID: 7992144 Review.
-
Clinical services research.Schizophr Bull. 1992;18(4):561-626. doi: 10.1093/schbul/18.4.561. Schizophr Bull. 1992. PMID: 1439613 Review. No abstract available.
Cited by
-
A 6-week, randomized, multicentre, open-label study comparing efficacy and tolerability of amisulpride at a starting dose of 400 mg/day versus 800 mg/day in patients with acute exacerbations of schizophrenia.Clin Drug Investig. 2012 Nov;32(11):735-45. doi: 10.1007/s40261-012-0002-8. Clin Drug Investig. 2012. PMID: 23018281 Clinical Trial.
-
Quality of longer term mental health facilities in Europe: validation of the quality indicator for rehabilitative care against service users' views.PLoS One. 2012;7(6):e38070. doi: 10.1371/journal.pone.0038070. Epub 2012 Jun 4. PLoS One. 2012. PMID: 22675508 Free PMC article.
-
Frequent attenders in general medical practice in Italy: a preliminary report on clinical variables related to low functioning.Neuropsychiatr Dis Treat. 2018 Dec 24;15:115-125. doi: 10.2147/NDT.S179013. eCollection 2019. Neuropsychiatr Dis Treat. 2018. PMID: 30636877 Free PMC article.
-
Ribosomal DNA gene copies are increased in blood and brain of Japanese schizophrenia patients.PLoS One. 2023 Jan 20;18(1):e0280694. doi: 10.1371/journal.pone.0280694. eCollection 2023. PLoS One. 2023. PMID: 36662828 Free PMC article.
-
Mild Behavioral Impairment in Psychogeriatric Patients: Clinical Features and Psychopathology Severity.J Clin Med. 2023 Aug 21;12(16):5423. doi: 10.3390/jcm12165423. J Clin Med. 2023. PMID: 37629464 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical